TransCanna Holdings Inc
TransCanna Holdings Inc., through its subsidiaries, engages in the manufacturing, transportation, and distribution of cannabis related products in the United States. It provides cannabis for licensed operators involved in the cultivation, processing, distribution, and crop management in California. The company was incorporated in 2017 and is headquartered in West Vancouver, Canada.
TransCanna Holdings Inc (TCNAF) - Net Assets
Latest net assets as of August 2022: $2.06 Million USD
Based on the latest financial reports, TransCanna Holdings Inc (TCNAF) has net assets worth $2.06 Million USD as of August 2022.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($32.51 Million) and total liabilities ($30.44 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $2.06 Million |
| % of Total Assets | 6.34% |
| Annual Growth Rate | 114.6% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 99.3 |
TransCanna Holdings Inc - Net Assets Trend (2017–2021)
This chart illustrates how TransCanna Holdings Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for TransCanna Holdings Inc (2017–2021)
The table below shows the annual net assets of TransCanna Holdings Inc from 2017 to 2021.
| Year | Net Assets | Change |
|---|---|---|
| 2021-11-30 | $3.26 Million | -65.10% |
| 2020-11-30 | $9.34 Million | -43.83% |
| 2019-11-30 | $16.63 Million | +6685.89% |
| 2018-11-30 | $-252.45K | -264.31% |
| 2017-11-30 | $153.64K | -- |
Equity Component Analysis
This analysis shows how different components contribute to TransCanna Holdings Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 5816376900.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (November 2021)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $51.47 Million | 1579.37% |
| Other Comprehensive Income | $10.14 Million | 311.30% |
| Total Equity | $3.26 Million | 100.00% |
TransCanna Holdings Inc Competitors by Market Cap
The table below lists competitors of TransCanna Holdings Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
AFLT3F
SA:AFLT3F
|
$11.27K |
|
BloomZ Inc. Ordinary Shares
NASDAQ:BLMZ
|
$11.28K |
|
SH PHARMACEU -H-
BE:S1R
|
$11.30K |
|
CFECAPITAL S. De R.L. De C.V
MX:FCFE18
|
$11.30K |
|
Road Studio S.A.
WAR:RST
|
$11.24K |
|
Colombo Fort Investments PLC
CM:CFIN0000
|
$11.23K |
|
US Lighting Group Inc
PINK:USLG
|
$11.23K |
|
ORVANA MINERALS (O6M.SG)
STU:O6M
|
$11.23K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in TransCanna Holdings Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2020 to 2021, total equity changed from 9,338,461 to 3,258,844, a change of -6,079,617 (-65.1%).
- Net loss of 13,092,658 reduced equity.
- New share issuances of 2,153,974 increased equity.
- Other comprehensive income increased equity by 2,088,813.
- Other factors increased equity by 2,770,254.
Equity Change Factors (2020 to 2021)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-13.09 Million | -401.76% |
| Share Issuances | $2.15 Million | +66.1% |
| Other Comprehensive Income | $2.09 Million | +64.1% |
| Other Changes | $2.77 Million | +85.01% |
| Total Change | $- | -65.10% |
Book Value vs Market Value Analysis
This analysis compares TransCanna Holdings Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-11-30 | $0.01 | $0.00 | x |
| 2018-11-30 | $-0.02 | $0.00 | x |
| 2019-11-30 | $0.60 | $0.00 | x |
| 2020-11-30 | $0.21 | $0.00 | x |
| 2021-11-30 | $0.06 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently TransCanna Holdings Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -401.76%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -327.40%
- • Asset Turnover: 0.16x
- • Equity Multiplier: 7.87x
- Recent ROE (-401.76%) is below the historical average (-172.96%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | -124.55% | 0.00% | 0.00x | 1.10x | $-206.72K |
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.14 Million |
| 2019 | -155.06% | -10721.43% | 0.01x | 1.97x | $-27.44 Million |
| 2020 | -183.43% | -246.21% | 0.26x | 2.83x | $-18.06 Million |
| 2021 | -401.76% | -327.40% | 0.16x | 7.87x | $-13.42 Million |
Industry Comparison
This section compares TransCanna Holdings Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| TransCanna Holdings Inc (TCNAF) | $2.06 Million | -124.55% | 14.77x | $11.27K |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |